Two-Sigma-Advisers-Lp

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
2,360
Total Value
44417954494
Accession Number
0000899140-25-000679
Form Type
13F-HR
Manager Name
Two-Sigma-Advisers-Lp
Data Enrichment
97% identified
2,287 identified73 unidentified

Holdings

2,360 positions • $44.4B total value
Manager:
Search and click to pin securities to the top
Page 117 of 118
83307B101
Shares:35.5K
Value:$50.1K
% of Portfolio:0.0% ($50.1K/$44.4B)
Elevation Oncology, Inc.
Shares:193.1K
Value:$50.0K
% of Portfolio:0.0% ($50.0K/$44.4B)
ARKO Corp.
Shares:12.1K
Value:$47.8K
% of Portfolio:0.0% ($47.8K/$44.4B)
Lyra Therapeutics, Inc.
Shares:364.5K
Value:$46.0K
% of Portfolio:0.0% ($46.0K/$44.4B)
Athira Pharma, Inc.
Shares:157.1K
Value:$44.8K
% of Portfolio:0.0% ($44.8K/$44.4B)
Braemar Hotels & Resorts Inc.
Shares:17.8K
Value:$44.3K
% of Portfolio:0.0% ($44.3K/$44.4B)
AC Immune SA
Shares:23.6K
Value:$44.2K
% of Portfolio:0.0% ($44.2K/$44.4B)
Inotiv, Inc.
Shares:19.9K
Value:$44.0K
% of Portfolio:0.0% ($44.0K/$44.4B)
AIR INDUSTRIES GROUP
Shares:12.1K
Value:$42.1K
% of Portfolio:0.0% ($42.1K/$44.4B)
Arbutus Biopharma Corp
Shares:12.0K
Value:$41.9K
% of Portfolio:0.0% ($41.9K/$44.4B)
Adaptimmune Therapeutics PLC
Shares:206.7K
Value:$40.7K
% of Portfolio:0.0% ($40.7K/$44.4B)
ATOSSA THERAPEUTICS, INC.
Shares:56.9K
Value:$38.3K
% of Portfolio:0.0% ($38.3K/$44.4B)
GEE Group Inc.
Shares:189.2K
Value:$38.2K
% of Portfolio:0.0% ($38.2K/$44.4B)
68620P705
Shares:37.6K
Value:$38.0K
% of Portfolio:0.0% ($38.0K/$44.4B)
TELOS CORP
Shares:15.9K
Value:$37.8K
% of Portfolio:0.0% ($37.8K/$44.4B)
ACELYRIN, Inc.
Shares:15.1K
Value:$37.3K
% of Portfolio:0.0% ($37.3K/$44.4B)
Century Therapeutics, Inc.
Shares:76.9K
Value:$36.6K
% of Portfolio:0.0% ($36.6K/$44.4B)
Planet Labs PBC
Shares:10.6K
Value:$35.8K
% of Portfolio:0.0% ($35.8K/$44.4B)
Origin Materials, Inc.
Shares:48.8K
Value:$32.4K
% of Portfolio:0.0% ($32.4K/$44.4B)
Vigil Neuroscience, Inc.
Shares:17.9K
Value:$31.9K
% of Portfolio:0.0% ($31.9K/$44.4B)